// App-Quantinova.ai

89 : Multiplexed ion beam imaging (MIBI) uncovers adaptive immune responses associated with clinical outcomes in oral cavity squamous cell carcinoma treated with neoadjuvant PD-1 inhibitor

Researchers

Presenter

  • Raghav Padmanabhan

Principal Investigators

  • Hannah Knochelmann

  • Monirath Hav

  • Mate Nagy

  • Peng Si

  • Sweta Bajaj

  • Gregory Lesinski

  • David Neskey

  • Chrystal Paulos

Medical Centers

  • Emory University School of Medicine, Atlanta, GA

  • Sarah Cannon Research Institute, Charleston, SC, USA

  • Emory University, Charleston, SC, USA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Squamous cell carcinoma of the head and neck

Biomarkers

  • Dipeptidyl peptidase IV

  • Programmed cell death protein 1

Drug/Treatment

  • Nivolumab

Outcome

  • N/A

Study Design

  • Adaptive

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved